KR20220136529A - Hydrophilic-hydrophobic nanoporous membrane and manufacturing method thereof - Google Patents
Hydrophilic-hydrophobic nanoporous membrane and manufacturing method thereof Download PDFInfo
- Publication number
- KR20220136529A KR20220136529A KR1020210040941A KR20210040941A KR20220136529A KR 20220136529 A KR20220136529 A KR 20220136529A KR 1020210040941 A KR1020210040941 A KR 1020210040941A KR 20210040941 A KR20210040941 A KR 20210040941A KR 20220136529 A KR20220136529 A KR 20220136529A
- Authority
- KR
- South Korea
- Prior art keywords
- solution
- nanoporous membrane
- membrane
- hydrophobic
- hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 54
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 238000001523 electrospinning Methods 0.000 claims abstract description 23
- 229920001600 hydrophobic polymer Polymers 0.000 claims abstract description 15
- 230000005661 hydrophobic surface Effects 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 14
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 13
- 230000005660 hydrophilic surface Effects 0.000 claims abstract description 10
- 239000004814 polyurethane Substances 0.000 claims description 33
- 229920002635 polyurethane Polymers 0.000 claims description 32
- 239000003960 organic solvent Substances 0.000 claims description 17
- -1 polyethylene Polymers 0.000 claims description 16
- 239000004698 Polyethylene Substances 0.000 claims description 14
- 229920000573 polyethylene Polymers 0.000 claims description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 13
- 239000004743 Polypropylene Substances 0.000 claims description 13
- 229920001155 polypropylene Polymers 0.000 claims description 13
- 229920001400 block copolymer Polymers 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 239000004584 polyacrylic acid Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 3
- 239000004800 polyvinyl chloride Substances 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- 239000000243 solution Substances 0.000 description 25
- 239000000835 fiber Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 230000002209 hydrophobic effect Effects 0.000 description 8
- 229920001992 poloxamer 407 Polymers 0.000 description 6
- 239000011324 bead Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 238000009987 spinning Methods 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 4
- 229920001897 terpolymer Polymers 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229920000428 triblock copolymer Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A61F13/00017—
-
- A61F13/00029—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01017—Non-adhesive bandages or dressings characterised by the material synthetic, e.g. polymer based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
- A61F13/01029—Non-adhesive bandages or dressings characterised by the structure of the dressing made of multiple layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00238—Wound bandages characterised by way of knitting or weaving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00255—Wound bandages in a special way pervious to air or vapours with pores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2509/00—Medical; Hygiene
- D10B2509/02—Bandages, dressings or absorbent pads
- D10B2509/022—Wound dressings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Manufacturing & Machinery (AREA)
- Mechanical Engineering (AREA)
- Textile Engineering (AREA)
- Materials For Medical Uses (AREA)
Abstract
본 발명은 친수성-소수성을 양면에 갖는 나노 다공성 막과 이의 제조방법에 관한 것으로, 보다 상세하게는 소수성 고분자를 포함하는 제1용액이 전기방사되어 형성된 소수성면 및 친수성 고분자를 포함하는 제2용액이 전기방사되어 형성된 친수성면을 포함하는, 나노 다공성 막과 이의 제조방법을 제공한다. 상기 나노 다공성 막은 생체적합성이 우수해 의료용도로 활용될 수 있다.The present invention relates to a nanoporous membrane having hydrophilicity-hydrophobicity on both sides and a method for manufacturing the same, and more particularly, a hydrophobic surface formed by electrospinning a first solution containing a hydrophobic polymer and a second solution containing a hydrophilic polymer To provide a nanoporous membrane comprising a hydrophilic surface formed by electrospinning and a method for manufacturing the same. The nanoporous membrane has excellent biocompatibility and can be used for medical purposes.
Description
본 발명은 친수성-소수성을 양면에 갖는 나노 다공성 막 및 이의 제조방법에 관한 것이다.The present invention relates to a nanoporous membrane having hydrophilicity-hydrophobicity on both sides and a method for preparing the same.
수술 처치를 받은 수술 부위를 보호하기 위해 수술용 커버재가 일반적으로 사용된다. 예를 들어, 치과 수술을 받은 치조골 조직, 정형외과 수술을 받은 뼈 조직, 외과 수술 또는 산부인과 수술을 받은 장기 조직 등 다양한 수술 부위에 수술용 커버재가 사용된다.A surgical cover material is generally used to protect the surgical site undergoing surgical treatment. For example, a surgical cover material is used for various surgical sites, such as alveolar bone tissue that has undergone dental surgery, bone tissue that has undergone orthopedic surgery, and organ tissue that has undergone surgical or gynecological surgery.
수술용 커버재로서는 얇은 거즈(gauze)나 필름(film)이 일반적으로 사용되고 있다. 거즈 형태의 커버재는 다수의 기공들을 보유한 특징을 갖는데, 그 기공들의 크기가 조직 재생 시에 선호되는 크기인 10 내지 100 ㎛에 비해 과도하게 크기 때문에 조직 재생을 촉진하는 효과를 기대하기는 어렵고, 오히려 그 기공들에 의해 세균 또는 주변 조직이 수술 부위에 침투하기 쉬운 단점이 있다. 필름 형태의 커버재는 기공이 없는 치밀 구조를 갖기 때문에 세균 또는 주변 조직이 수술 부위에 침투하는 것을 막는 데에는 효과적이지만 기공 구조로 인한 조직 재생 촉진 효과는 전혀 기대할 수 없다.A thin gauze or film is generally used as a surgical cover material. The gauze-type cover material has a feature of having a large number of pores, and since the size of the pores is excessively large compared to 10 to 100 μm, which is a preferred size for tissue regeneration, it is difficult to expect an effect of promoting tissue regeneration, rather There is a disadvantage that bacteria or surrounding tissues are easy to penetrate into the surgical site by the pores. Since the film-type cover material has a dense structure without pores, it is effective in preventing bacteria or surrounding tissues from penetrating into the surgical site, but the effect of promoting tissue regeneration due to the pore structure cannot be expected at all.
한편, 상처난 피부에는 이를 보호하기 위한 피부용 커버재가 흔히 사용된다. 대표적인 피부용 커버재로는 상처 부위에 직접 닿는 폼층(foam layer) 및 이의 부착을 돕는 접착 테이프로 구성된 형태를 들 수 있다.On the other hand, a skin cover material for protecting the wounded skin is often used. A typical skin cover material may include a form composed of a foam layer directly in contact with a wound and an adhesive tape that helps the adhesion thereof.
여기서 폼층은 상처 부위에 외부 자극이 가해지는 것을 막는 역할 및 상처 부위의 빠른 회복을 위해 습윤 환경을 조성하는 역할을 하는 것으로서, 일반적으로 폴리우레탄 폼이 사용된바 있다.Here, the foam layer serves to prevent external stimuli from being applied to the wound site and to create a wet environment for the rapid recovery of the wound site, and in general, polyurethane foam has been used.
전술한 문제를 해결하기 위하여, 본 발명은 친수성과 소수성을 양면에 갖도록 제작된 나노 다공성 막과 이의 제조방법 제공하고자 한다.In order to solve the above problems, the present invention is to provide a nanoporous membrane manufactured to have hydrophilicity and hydrophobicity on both sides and a method for manufacturing the same.
상술한 문제를 해결하기 위해, 본 발명은 소수성 고분자를 포함하는 제1용액이 전기방사되어 형성된 소수성면 및 친수성 고분자를 포함하는 제2용액이 전기방사되어 형성된 친수성면을 포함하는, 나노 다공성 막을 제공한다.In order to solve the above problems, the present invention provides a nanoporous membrane comprising a hydrophobic surface formed by electrospinning a first solution containing a hydrophobic polymer and a hydrophilic surface formed by electrospinning a second solution containing a hydrophilic polymer do.
본 발명의 일구현예로, 상기 소수성 고분자는 폴리우레탄일 수 있다.In one embodiment of the present invention, the hydrophobic polymer may be polyurethane.
본 발명의 다른 구현예로, 상기 친수성 고분자는 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체일 수 있다.In another embodiment of the present invention, the hydrophilic polymer may be a terpolymer of polyethylene oxide-polypropylene oxide-polyethylene oxide.
본 발명의 또다른 구현예로, 상기 제1용액은 폴리우레탄 및 유기용매를 포함하는 것일 수 있다.In another embodiment of the present invention, the first solution may include polyurethane and an organic solvent.
본 발명의 또다른 구현예로, 제2용액은 폴리우레탄, 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체 및 유기용매를 포함하는 것일 수 있다.In another embodiment of the present invention, the second solution may include polyurethane, a terpolymer of polyethylene oxide-polypropylene oxide-polyethylene oxide, and an organic solvent.
본 발명의 또다른 구현예로, 상기 제1용액은, 폴리우레탄 5 내지 30 중량% 및 잔부의 유기용매를 포함하는 것일 수 있다.In another embodiment of the present invention, the first solution may include 5 to 30% by weight of polyurethane and the balance of the organic solvent.
본 발명의 또다른 구현예로, 상기 제2용액은, 폴리우레탄 5 내지 30 중량%, 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체 1 내지 20 중량% 및 잔부의 유기용매를 포함하는 것일 수 있다.In another embodiment of the present invention, the second solution contains 5 to 30% by weight of polyurethane, 1 to 20% by weight of a ternary block copolymer of polyethylene oxide-polypropylene oxide-polyethylene oxide, and the remainder of the organic solvent it could be
본 발명의 또다른 구현예로, 상기 나노 다공성 막은 의료용인 것일 수 있다.In another embodiment of the present invention, the nano-porous membrane may be for medical use.
또한, 본 발명은 소수성 고분자를 포함하는 제1용액을 준비하는 단계(S1);In addition, the present invention comprises the steps of preparing a first solution containing a hydrophobic polymer (S1);
친수성 고분자를 포함하는 제2용액을 준비하는 단계(S2);Preparing a second solution containing a hydrophilic polymer (S2);
상기 제1용액을 전기방사하여 소수성면을 형성하는 단계(S3); 및forming a hydrophobic surface by electrospinning the first solution (S3); and
상기 소수성면 위에 제2용액을 전기방사하여 친수성면을 형성하는 단계(S4)를 포함하는, 나노 다공성 막의 제조방법을 제공한다.Electrospinning a second solution on the hydrophobic surface to form a hydrophilic surface (S4), it provides a method for producing a nano-porous membrane.
본 발명은 소수성면 및 친수성면을 포함하는, 나노 다공성 막을 제공하는 것으로, 필터로서의 막에 더하여 의료용도로 체내/체외에 부착 및 이식이 가능한 의료용 막으로 활용될 수 있다.The present invention is to provide a nano-porous membrane comprising a hydrophobic side and a hydrophilic side, and can be used as a medical membrane that can be attached and implanted in/outside the body for medical purposes in addition to a membrane as a filter.
도 1은 본 발명의 나노 다공성 막의 모식도를 나타낸 것이다.
도 2는 본 발명의 나노 다공성 막의 전기방사 조건에 따른 구현조건을 나타낸 것이다.
도 3은 나노 다공성 막의 표면 조건에 따른 유체의 거동을 확인한 결과를 나타낸 것이다.
도 4는 나노 다공성 막의 단면을 나타낸 것이다.
도 5는 나노 다공성 막의 단면에서 소수성 표면 및 친수성 표면을 구분하여 나타낸 것이다.
도 6은 나노 다공성 막에서 PU면을 살펴본 결과(좌) 및 PU-PF면을 살펴본 결과(우)를 나타낸 것이다.
도 7은 본 발명의 나노 다공성 막의 양면에 대하여 접촉각을 확인한 결과를 나타낸 것이다.
도 8은 PU/PU-PF 야누스 멤브레인의 형광비즈 실험 결과를 나타낸 것이다.1 shows a schematic diagram of the nanoporous membrane of the present invention.
Figure 2 shows the implementation conditions according to the electrospinning conditions of the nanoporous membrane of the present invention.
3 shows the results of confirming the behavior of the fluid according to the surface conditions of the nanoporous membrane.
4 shows a cross-section of the nanoporous membrane.
5 is a view showing the hydrophobic surface and the hydrophilic surface separately in the cross section of the nanoporous membrane.
6 shows the results of examining the PU surface (left) and the PU-PF surface (right) in the nanoporous membrane.
7 shows the result of confirming the contact angle with respect to both surfaces of the nanoporous membrane of the present invention.
8 shows the results of the fluorescent beads experiment of the PU/PU-PF Janus membrane.
본 발명은 친수성-소수성을 양면에 갖는 나노 다공성 막 및 이의 제조방법에 관한 것으로, 본 발명의 나노 다공성 막은 도 1에 나타낸 것과 같이 친수성 재료와 소수성 재료를 순차적으로 전기방사하여 하나의 멤브레인(membrane)을 형성한 것으로, 하나의 membrane에서 친수성, 소수성 모두를 가지는 양면성을 보이는 특징을 갖는다.The present invention relates to a nanoporous membrane having hydrophilicity and hydrophobicity on both sides and a method for manufacturing the same. It has the characteristic of showing both hydrophilicity and hydrophobicity in one membrane.
상기 멤브레인은 도 2에 나타낸 것과 같이, 전기방사 조건을 조절하여 소수성 면 또는 친수성 면이 일부 또는 전체에 형성될 수 있다.As shown in FIG. 2 , the membrane may have a hydrophobic surface or a hydrophilic surface partially or entirely formed by controlling the electrospinning conditions.
상기 소수성 재료 및 친수성 재료의 종류에는 제한은 없으나, 바람직하게는 생체 안정성이 우수한 것을 사용해야한다.There is no limitation on the type of the hydrophobic material and the hydrophilic material, but preferably, one having excellent biostability should be used.
상기 소수성 고분자는 폴리우레탄, 폴리에틸렌, 폴리염화비닐, 폴리스티렌, 및 폴리프로필렌으로 이루어지는 군으로부터 선택되는 1종 이상일 수 있고, 친수성 고분자는 폴리아크릴산, 폴리에틸렌글리콜, 폴리비닐피롤리돈, 폴리비닐알콜, 및 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체로 이루어지는 군으로부터 선택되는 1종 이상일 수 있다.The hydrophobic polymer may be at least one selected from the group consisting of polyurethane, polyethylene, polyvinyl chloride, polystyrene, and polypropylene, and the hydrophilic polymer is polyacrylic acid, polyethylene glycol, polyvinylpyrrolidone, polyvinyl alcohol, and It may be at least one selected from the group consisting of a terpolymer of polyethylene oxide-polypropylene oxide-polyethylene oxide.
보다 바람직하게는 본 발명에서와 같이 친수성 재료로 PU (Polyurethane)와 PF (Pluronic F127)의 혼합물, 소수성 재료로 PU 사용하는 것이 바람직하다. 상기 PF는 Pluronic F127( 폴리에틸렌옥사이드(PEO : polyethylene oxide)-폴리프로필렌옥사이드(PPO : poly propylene oxide)-폴리에틸렌옥사이드의 삼원블럭공중합체(triblock copolymer))을 의미하는 것이다.More preferably, as in the present invention, it is preferable to use a mixture of PU (Polyurethane) and PF (Pluronic F127) as a hydrophilic material and PU as a hydrophobic material. The PF is Pluronic F127 (polyethylene oxide (PEO: polyethylene oxide) - polypropylene oxide (PPO: poly propylene oxide) - means a triblock copolymer of polyethylene oxide (triblock copolymer).
즉 본 발명은 소수성 고분자를 포함하는 제1용액이 전기방사되어 형성된 소수성면 및 친수성 고분자를 포함하는 제2용액이 전기방사되어 형성된 친수성면을 포함하는, 나노 다공성 막을 제공한다.That is, the present invention provides a nanoporous membrane comprising a hydrophobic surface formed by electrospinning a first solution containing a hydrophobic polymer and a hydrophilic surface formed by electrospinning a second solution containing a hydrophilic polymer.
또한, 본 발명은 소수성 고분자를 포함하는 제1용액을 준비하는 단계(S1);In addition, the present invention comprises the steps of preparing a first solution containing a hydrophobic polymer (S1);
친수성 고분자를 포함하는 제2용액을 준비하는 단계(S2);Preparing a second solution containing a hydrophilic polymer (S2);
상기 제1용액을 전기방사하여 소수성면을 형성하는 단계(S3); 및forming a hydrophobic surface by electrospinning the first solution (S3); and
상기 소수성면 위에 제2용액을 전기방사하여 친수성면을 형성하는 단계(S4)를 포함하는, 나노 다공성 막의 제조방법을 제공한다.Electrospinning a second solution on the hydrophobic surface to form a hydrophilic surface (S4), it provides a method for producing a nano-porous membrane.
본 발명의 일구현예로서 상기 제1용액은 폴리우레탄 및 유기용매를 포함하는 것이고, 제2용액은 폴리우레탄, 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체 및 유기용매를 포함하는 것이다.As an embodiment of the present invention, the first solution includes polyurethane and an organic solvent, and the second solution includes polyurethane, a terpolymer of polyethylene oxide-polypropylene oxide-polyethylene oxide, and an organic solvent. .
보다 상세하게 상기 제1용액은, 폴리우레탄 5 내지 30 중량% 및 잔부의 유기용매를 포함하는 것일 수 있고, 상기 제2용액은, 폴리우레탄 5 내지 30 중량%, 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체 1 내지 20 중량% 및 잔부의 유기용매를 포함하는 것일 수 있다. 상기 범위에 한정되는 것은 아니나, 상기와 같은 함량 범위에서 우수한 물성이 확인된다. 상기 농도는 고분자간 인력과 반발력에 의해 결정되는 것으로, fiber의 형성과 평균직경을 조절할 수 있다. 상기 범위 미만으로 고분자의 농도가 너무 낮을 때는 bead를 형성할 수 있고, 상기 범위를 초과하여 고분자의 함량이 너무 높을 시엔 용액이 건조되기 쉬워 방사가 어렵고 섬유의 평균 직경이 증가할 수 있다.In more detail, the first solution may include 5 to 30% by weight of polyurethane and the remainder of the organic solvent, and the second solution is, 5 to 30% by weight of polyurethane, polyethylene oxide-polypropylene oxide-polyethylene It may contain 1 to 20% by weight of the ternary block copolymer of oxide and the balance of the organic solvent. Although not limited to the above range, excellent physical properties are confirmed in the content range as described above. The concentration is determined by the attractive and repulsive forces between the polymers, and the formation and average diameter of fibers can be controlled. When the polymer concentration is too low below the above range, beads can be formed, and when the polymer content is too high over the above range, the solution is easy to dry, so spinning is difficult and the average diameter of the fibers can be increased.
상기 전기방사는 집전판 거리 10 내지 50 cm, 방사속도 0.01 내지 10 mL/h, 인가전압 5 내지 30 kV, 집전판 속도 1 내지 30 rpm으로, 10~30 G의 바늘을 이용하여 수행되는 것일 수 있다.The electrospinning may be performed using a needle of 10 to 30 G at a current collector plate distance of 10 to 50 cm, a spinning speed of 0.01 to 10 mL/h, an applied voltage of 5 to 30 kV, and a current collecting plate speed of 1 to 30 rpm. have.
상기 집전판 거리는 전기방사 시 형성되는 fiber의 굵기, membrane 전체의 폭을 조절하는 것으로, 거리가 짧을수록 fiber의 굵기는 증가하며 membrane의 폭은 감소하는 것이다. 만약 거리가 10cm 미만으로 너무 짧을 경우 fiber 형성 전 충분한 시간의 확보가 어렵고, 50 cm를 초과하여 거리가 너무 길 경우 bead의 발생 확률이 높다.The distance of the collector plate controls the thickness of the fiber formed during electrospinning and the width of the entire membrane. As the distance decreases, the thickness of the fiber increases and the width of the membrane decreases. If the distance is too short (less than 10 cm), it is difficult to secure sufficient time before fiber formation.
상기 방사 속도는 형성되는 fiber의 굵기 및 뭉침을 조절하는 것으로, 방사 속도가 0.01 mL/h 미만으로 느리면 분말의 형태로 나타나 fiber의 뭉침이 증가하며, 방사 속도가 10 mL/h를 초과하여 매우 빠를 경우 건조시간이 짧고 분사력이 낮아 fiber의 직경이 두껍고 bead 발생 확률이 있다.The spinning speed is to control the thickness and aggregation of the fibers to be formed. If the spinning speed is as low as 0.01 mL/h, it appears in the form of a powder, resulting in increased fiber aggregation, and is very fast when the spinning speed exceeds 10 mL/h. In this case, the drying time is short and the blowing force is low, so the diameter of the fiber is thick and there is a possibility of bead occurrence.
인가 전압은 전기방사 시 전도를 조절하는 것으로, 인가 전압이 5 kV 미만으로 낮을 시 fiber의 형성이 어렵고, 30 kV를 초과하여 높을 시 fiber의 끊김 현상이 증가할 수 있다. 상기 바늘 게이지는 형성되는 fiber 굵기를 조절하는 것으로, 10~30G의 바늘을 이용할 수 있다. The applied voltage controls conduction during electrospinning. When the applied voltage is lower than 5 kV, it is difficult to form a fiber, and when it is higher than 30 kV, the fiber breakage phenomenon may increase. The needle gauge controls the thickness of the formed fiber, and a needle of 10 to 30 G may be used.
상기 나노 다공성 막은 20 um 이하의 마이크로사이즈 입자를 분리가능한 것으로, 상기 나노 다공성 막은 의료용으로 활용되는 것으로 생체적합성이 우수해 체내/체외에 부착 및 이식이 용이한 것을 특징으로 한다. 의료용으로 이용할 경우 부착 부위 외부로 소수성을 갖는 면이 노출되도록 위치시켜, 외부에서 발생하는 자극 또는 이물질의 유입을 방지할 수 있다.The nano-porous membrane is capable of separating micro-sized particles of 20 μm or less, and the nano-porous membrane is used for medical purposes and has excellent biocompatibility, and is characterized in that it is easy to attach and implant inside/outside the body. When used for medical purposes, the hydrophobic surface is exposed outside the attachment site, so that external stimulation or inflow of foreign substances can be prevented.
이하에서는 본 발명의 바람직한 실시예를 상세하게 설명한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐리게 할 수 있다고 판단되는 경우 그 상세한 설명을 생략하기로 한다. 명세서 전체에서, 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한, 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있음을 의미한다.Hereinafter, preferred embodiments of the present invention will be described in detail. In describing the present invention, if it is determined that a detailed description of a related known technology may obscure the gist of the present invention, the detailed description thereof will be omitted. Throughout the specification, when a part "includes" a certain component, it means that other components may be further included, rather than excluding other components, unless otherwise stated.
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 특정 실시예를 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.Since the present invention can apply various transformations and can have various embodiments, specific embodiments are illustrated and described in detail in the detailed description. However, this is not intended to limit the present invention to specific embodiments, and it should be understood to include all modifications, equivalents and substitutes included in the spirit and scope of the present invention.
발명에서 사용한 용어는 단지 특정한 실시예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 발명에서, 포함하다 또는 가지다 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.Terms used in the present invention are only used to describe specific embodiments, and are not intended to limit the present invention. The singular expression includes the plural expression unless the context clearly dictates otherwise. In the present invention, the terms include or have is intended to designate that a feature, number, step, operation, component, part, or combination thereof described in the specification exists, but one or more other features, number, step , it should be understood that it does not preclude in advance the possibility of the presence or addition of an operation, component, part, or combination thereof.
이하, 본 발명의 바람직한 실시예를 첨부한 도면을 참조하여 당해 분야의 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 설명하기로 한다. 또한, 본 발명을 설명함에 있어 관련된 공지의 기능 또는 공지의 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명을 생략하기로 한다. 그리고 도면에 제시된 어떤 특징들은 설명의 용이함을 위해 확대 또는 축소 또는 단순화된 것이고, 도면 및 그 구성요소들이 반드시 적절한 비율로 도시되어 있지는 않다. 그러나 당업자라면 이러한 상세 사항들을 쉽게 이해할 것이다.Hereinafter, preferred embodiments of the present invention will be described so that those of ordinary skill in the art can easily implement them with reference to the accompanying drawings. In addition, in describing the present invention, if it is determined that a detailed description of a related known function or a known configuration may unnecessarily obscure the gist of the present invention, the detailed description thereof will be omitted. In addition, certain features presented in the drawings are enlarged, reduced, or simplified for ease of description, and the drawings and their components are not necessarily drawn to scale. However, those skilled in the art will readily appreciate these details.
[실시예][Example]
실시예 1 : PU/PU-PF 야누스 멤브레인의 제조Example 1: Preparation of PU/PU-PF Janus Membrane
소수성 layer 제작을 위한 용액을 합성하기 위해, 먼저 50 mL Tube에 THF와 DMF를 6:4 비율로 혼합하였다. 혼합된 용액에 대하여 15 wt%만큼의 PU를 준비하였다. 준비된 PU를 THF, DMF 혼합물에 넣고 완전히 용해될 때까지 stirring해주었다.In order to synthesize a solution for producing a hydrophobic layer, THF and DMF were mixed in a ratio of 6:4 in a 50 mL tube first. 15 wt% of PU was prepared with respect to the mixed solution. The prepared PU was put in a mixture of THF and DMF and stirred until completely dissolved.
또한 친수성 layer 제작을 위한 용액을 합성하기 위해 50 mL Tube에 THF와 DMF를 6:4 비율로 혼합하였다. 혼합된 용액에 대하여 15 wt%만큼의 PU와 9 wt%만큼의 PF를 준비하였다. 준비된 PU, PF를 THF, DMF 혼합물에 넣고 완전히 용해될 때까지 stirring해주었다.In addition, to synthesize a solution for producing a hydrophilic layer, THF and DMF were mixed in a ratio of 6:4 in a 50 mL tube. For the mixed solution, 15 wt% of PU and 9 wt% of PF were prepared. The prepared PU and PF were put into the THF and DMF mixture and stirred until completely dissolved.
준비된 소수성 layer 제작을 위한 용액 PU 용액 4 mL를 먼저 전기방사하여 소수성 layer를 제작한 후, 그 위에 친수성 layer 제작을 위한 PU-PF 용액을 2 mL 전기방사하여 친수성 layer를 형성하였다. 전기방사 완료된 Janus membrane을 40˚C에서 하루동안 건조시켜 유기용매를 제거해주었다. 상기 전기방사의 조건은 하기 표 1에 나타내었다.A hydrophobic layer was prepared by electrospinning 4 mL of a PU solution for preparing the prepared hydrophobic layer, and then 2 mL of a PU-PF solution for producing a hydrophilic layer was electrospun thereon to form a hydrophilic layer. The electrospinning Janus membrane was dried at 40 ˚C for one day to remove the organic solvent. The conditions of the electrospinning are shown in Table 1 below.
실시예 2. 멤브레인의 특성 확인Example 2. Confirmation of membrane properties
실시예 1에서 제조된 멤브레인의 소수성 및 친수성을 확인하기 위해서, 소수성 표면 또는 친수성 표면에 잉크를 떨어뜨려주었다. 도 3에서 확인되는 것과 같이, 소수성 면에서는 잉크가 흡수되지 않았으나, 친수성 면에는 잘 흡수되었다. In order to confirm the hydrophobicity and hydrophilicity of the membrane prepared in Example 1, ink was dropped on the hydrophobic surface or the hydrophilic surface. As can be seen in FIG. 3 , the ink was not absorbed on the hydrophobic side, but was well absorbed on the hydrophilic side.
제조된 멤브레인의 단면적을 촬영하여 도 4에 나타내었다. 평균 두께는 137.36 um으로 나타났다. 보다 상세하게 나타낸 도 5에서 확인되는 것과 같이, 폴리우레탄(PU)으로 형성된 소수성면과 폴리우레탄-플루로닉(PU-PF)으로 형성된 친수성면이 공존하는 것이 확인되었다.The cross-sectional area of the prepared membrane was photographed and shown in FIG. 4 . The average thickness was found to be 137.36 um. As confirmed in FIG. 5 shown in more detail, it was confirmed that the hydrophobic side formed of polyurethane (PU) and the hydrophilic side formed of polyurethane-pluronic (PU-PF) coexist.
상기 PU 면을 살펴본 결과를 도 6의 좌측에 나타내었고, PU-PF면을 살펴본 결과를 도 6 우측에 나타내었다. 상이한 형태를 나타난다는 것이 확인된다.The results of examining the PU surface are shown on the left side of FIG. 6 , and the results of examining the PU-PF surface are shown on the right side of FIG. 6 . It is confirmed that different forms appear.
또한, 상기 PU면과 PU-PF면에 물을 떨어뜨려 그 접촉각을 확인하였다. 그 결과 도 7에 나타낸 것과 같이 PU면에서는 소수성에 의해 접촉각이 크게 나타났으며, PU-PF면에서는 물방울이 퍼져 나타나는 것을 알 수 있다.In addition, by dropping water on the PU surface and the PU-PF surface, the contact angle was confirmed. As a result, as shown in FIG. 7 , it can be seen that the contact angle was large on the PU surface due to hydrophobicity, and the water droplets spread on the PU-PF surface.
아울러, PU/PU-PF 야누스 멤브레인의 형광비즈 실험 결과를 도 8에 나타내었다. 도 8에서 확인할 수 있는 것과 같이 PU-PF면에서는 형광비즈가 확인되었으나 PU면에서는 확인되지 않아, 상기 멤브레인에 입자 차단효과가 있음을 알 수 있다. In addition, the results of the fluorescent beads experiment of the PU/PU-PF Janus membrane are shown in FIG. 8 . As can be seen in FIG. 8 , fluorescent beads were confirmed on the PU-PF surface, but not on the PU surface, indicating that the membrane had a particle blocking effect.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적 기술은 단지 바람직한 실시 양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.As a specific part of the present invention has been described in detail above, for those of ordinary skill in the art, it is clear that this specific description is only a preferred embodiment, and the scope of the present invention is not limited thereby. will be. Accordingly, it is intended that the substantial scope of the present invention be defined by the appended claims and their equivalents.
Claims (16)
상기 소수성 고분자는 폴리우레탄, 폴리에틸렌, 폴리염화비닐, 폴리스티렌, 및 폴리프로필렌으로 이루어지는 군으로부터 선택되는 1종 이상인 것을 특징으로 하는, 나노 다공성 막.According to claim 1,
The hydrophobic polymer is a nanoporous membrane, characterized in that at least one selected from the group consisting of polyurethane, polyethylene, polyvinyl chloride, polystyrene, and polypropylene.
상기 친수성 고분자는 폴리아크릴산, 폴리에틸렌글리콜, 폴리비닐피롤리돈, 폴리비닐알콜, 및 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체로 이루어지는 군으로부터 선택되는 1종 이상인 것을 특징으로 하는, 나노 다공성 막.According to claim 1,
The hydrophilic polymer is characterized in that at least one selected from the group consisting of polyacrylic acid, polyethylene glycol, polyvinylpyrrolidone, polyvinyl alcohol, and a ternary block copolymer of polyethylene oxide-polypropylene oxide-polyethylene oxide, nano porous membrane.
상기 제1용액은 소수성 고분자 및 유기용매를 포함하는 것을 특징으로 하는, 나노 다공성 막.According to claim 1,
The first solution is a nanoporous membrane, characterized in that it contains a hydrophobic polymer and an organic solvent.
제2용액은 소수성 고분자, 친수성 고분자 및 유기용매를 포함하는 것을 특징으로 하는, 나노 다공성 막.According to claim 1,
The second solution is characterized in that it contains a hydrophobic polymer, a hydrophilic polymer and an organic solvent, nanoporous membrane.
상기 제1용액은, 폴리우레탄 5 내지 30 중량% 및 잔부의 유기용매를 포함하는 것을 특징으로 하는, 나노 다공성 막.5. The method of claim 4,
The first solution, 5 to 30% by weight of polyurethane and the balance of the organic solvent, characterized in that it comprises a nanoporous membrane.
상기 제2용액은, 폴리우레탄 5 내지 30 중량%, 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체 1 내지 20 중량% 및 잔부의 유기용매를 포함하는 것을 특징으로 하는, 나노 다공성 막.6. The method of claim 5,
The second solution, polyurethane 5 to 30% by weight, polyethylene oxide-polypropylene oxide-polyethylene oxide ternary block copolymer 1 to 20% by weight and the balance of the organic solvent, characterized in that it comprises a nanoporous membrane.
상기 나노 다공성 막은 의료용인 것을 특징으로 하는, 나노 다공성 막.According to claim 1,
The nano-porous membrane, characterized in that for medical use, nano-porous membrane.
친수성 고분자를 포함하는 제2용액을 준비하는 단계(S2);
상기 제1용액을 전기방사하여 소수성면을 형성하는 단계(S3); 및
상기 소수성면 위에 제2용액을 전기방사하여 친수성면을 형성하는 단계(S4)를 포함하는, 나노 다공성 막의 제조방법.Preparing a first solution containing a hydrophobic polymer (S1);
Preparing a second solution containing a hydrophilic polymer (S2);
forming a hydrophobic surface by electrospinning the first solution (S3); and
Electrospinning a second solution on the hydrophobic surface to form a hydrophilic surface (S4), the method for producing a nanoporous membrane.
상기 소수성 고분자는 폴리우레탄, 폴리에틸렌, 폴리염화비닐, 폴리스티렌, 및 폴리프로필렌인 것을 특징으로 하는, 나노 다공성 막의 제조방법.10. The method of claim 9,
The hydrophobic polymer is polyurethane, polyethylene, polyvinyl chloride, polystyrene, and polypropylene, characterized in that the method for producing a nanoporous membrane.
상기 친수성 고분자는 폴리아크릴산, 폴리에틸렌글리콜, 폴리비닐피롤리돈, 폴리비닐알콜, 및 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체로 이루어지는 군으로부터 선택되는 1종 이상인 것을 특징으로 하는, 나노 다공성 막의 제조방법.10. The method of claim 9,
The hydrophilic polymer is characterized in that at least one selected from the group consisting of polyacrylic acid, polyethylene glycol, polyvinylpyrrolidone, polyvinyl alcohol, and a ternary block copolymer of polyethylene oxide-polypropylene oxide-polyethylene oxide, nano A method for producing a porous membrane.
상기 제1용액은 소수성 고분자 및 유기용매를 포함하는 것을 특징으로 하는, 나노 다공성 막의 제조방법.10. The method of claim 9,
The first solution is a method for producing a nanoporous membrane, characterized in that it contains a hydrophobic polymer and an organic solvent.
제2용액은 소수성 고분자, 친수성 고분자, 및 유기용매를 포함하는 것을 특징으로 하는, 나노 다공성 막의 제조방법.10. The method of claim 9,
The second solution is a method for producing a nanoporous membrane, characterized in that it contains a hydrophobic polymer, a hydrophilic polymer, and an organic solvent.
상기 제1용액은, 폴리우레탄 5 내지 30 중량% 및 잔부의 유기용매를 포함하는 것을 특징으로 하는, 나노 다공성 막의 제조방법.13. The method of claim 12,
The first solution is, characterized in that it comprises 5 to 30% by weight of polyurethane and the balance of the organic solvent, a method for producing a nanoporous membrane.
상기 제2용액은, 폴리우레탄 5 내지 30 중량%, 폴리에틸렌옥사이드-폴리프로필렌옥사이드-폴리에틸렌옥사이드의 삼원블럭공중합체 1 내지 20 중량% 및 잔부의 유기용매를 포함하는 것을 특징으로 하는, 나노 다공성 막의 제조방법.14. The method of claim 13,
The second solution, polyurethane 5 to 30% by weight, polyethylene oxide-polypropylene oxide-polyethylene oxide tertiary block copolymer 1 to 20% by weight and the balance, characterized in that it contains an organic solvent, the production of a nanoporous membrane Way.
상기 나노 다공성 막은 의료용인 것을 특징으로 하는, 나노 다공성 막의 제조방법.10. The method of claim 9,
The nanoporous membrane is a method of manufacturing a nanoporous membrane, characterized in that for medical use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210040941A KR20220136529A (en) | 2021-03-30 | 2021-03-30 | Hydrophilic-hydrophobic nanoporous membrane and manufacturing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210040941A KR20220136529A (en) | 2021-03-30 | 2021-03-30 | Hydrophilic-hydrophobic nanoporous membrane and manufacturing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220136529A true KR20220136529A (en) | 2022-10-11 |
Family
ID=83599202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020210040941A Ceased KR20220136529A (en) | 2021-03-30 | 2021-03-30 | Hydrophilic-hydrophobic nanoporous membrane and manufacturing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20220136529A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010031628A (en) | 1997-10-31 | 2001-04-16 | 메리 앤 턱커 | Waterborne polyurethane having film properties comparable to rubber |
-
2021
- 2021-03-30 KR KR1020210040941A patent/KR20220136529A/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010031628A (en) | 1997-10-31 | 2001-04-16 | 메리 앤 턱커 | Waterborne polyurethane having film properties comparable to rubber |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2374287T3 (en) | NON-WOVEN FIBER ASSEMBLIES. | |
| DE60008773T2 (en) | ELECTRO-SPUN FIBERS AND DEVICE FOR THIS | |
| US9035122B2 (en) | Wound dressing inhibiting lateral diffusion of absorbed exudate | |
| EP0327328A2 (en) | Adhesive-faced porous absorbent sheet and method of making same | |
| KR101828382B1 (en) | Nanofiber membrane for guided bone regeneration and manufacturing method thereof | |
| JP2018508243A (en) | Negative pressure wound dressing with an absorbent adhesive sealant layer | |
| KR20100133117A (en) | Nanofibers for dressing, dressing composites using the same, and a method of manufacturing the same | |
| KR100564366B1 (en) | Shielding membrane for tissue regeneration using nanofiber type nonwoven fabric and method for manufacturing same | |
| KR102656226B1 (en) | Hemostatic material comprising calcium carboxymethyl cellulose powder and water-soluble chitosan compound powder and process for preparing the same | |
| CN1913927A (en) | Medicated polyurethane foams | |
| JP4959310B2 (en) | Breathable adhesive tape | |
| KR20220136529A (en) | Hydrophilic-hydrophobic nanoporous membrane and manufacturing method thereof | |
| JP5646820B2 (en) | Wound treatment material | |
| JP2009089837A (en) | Wound dressing | |
| US12031235B2 (en) | Nanofiber composite membrane for guided bone regeneration, and manufacturing method therefor | |
| JP5544206B2 (en) | Fiber composite | |
| CN119074993A (en) | Seawater-proof self-adhesive rapid hemostatic wound dressing and preparation method thereof | |
| KR20240123766A (en) | Dressing patch using redox activity and manufacturing method thereof | |
| KR102402319B1 (en) | Cosmetic patch | |
| KR100612374B1 (en) | Hydrogel for wound treatment containing moisture release prevention layer and its manufacturing method | |
| KR20180076063A (en) | Wound dressing materials based on dextran and manufacturing method thereof | |
| JPH06245988A (en) | Material for coating wound | |
| KR101080380B1 (en) | Film for adhesion of hydrogel having enhanced adhesive strength and preparation method thereof | |
| KR100667292B1 (en) | Wound dressing materials | |
| KR101599029B1 (en) | Composite non-woven fabric and process for preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20210330 |
|
| PA0201 | Request for examination | ||
| PG1501 | Laying open of application | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20230227 Patent event code: PE09021S01D |
|
| E90F | Notification of reason for final refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20230706 Patent event code: PE09021S02D |
|
| E601 | Decision to refuse application | ||
| E801 | Decision on dismissal of amendment | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20230920 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20230706 Comment text: Final Notice of Reason for Refusal Patent event code: PE06011S02I Patent event date: 20230227 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| PE0801 | Dismissal of amendment |
Patent event code: PE08012E01D Comment text: Decision on Dismissal of Amendment Patent event date: 20230920 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20230906 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20230626 |
|
| E601 | Decision to refuse application | ||
| E801 | Decision on dismissal of amendment | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20240115 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20230706 Comment text: Final Notice of Reason for Refusal Patent event code: PE06011S02I Patent event date: 20230227 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| PE0801 | Dismissal of amendment |
Patent event code: PE08012E01D Comment text: Decision on Dismissal of Amendment Patent event date: 20240115 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20231212 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20230906 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20230626 |